Free Trial

ANTIPODES PARTNERS Ltd Has $74.11 Million Position in Cemex S.A.B. de C.V. (NYSE:CX)

Cemex logo with Construction background

ANTIPODES PARTNERS Ltd trimmed its holdings in shares of Cemex S.A.B. de C.V. (NYSE:CX - Free Report) by 13.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 13,208,763 shares of the construction company's stock after selling 2,048,147 shares during the quarter. Cemex makes up about 2.3% of ANTIPODES PARTNERS Ltd's investment portfolio, making the stock its 20th largest holding. ANTIPODES PARTNERS Ltd owned approximately 0.91% of Cemex worth $74,107,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in CX. Allworth Financial LP boosted its position in shares of Cemex by 7.4% in the first quarter. Allworth Financial LP now owns 27,651 shares of the construction company's stock worth $157,000 after purchasing an additional 1,906 shares during the period. Cetera Investment Advisers boosted its position in shares of Cemex by 8.4% in the fourth quarter. Cetera Investment Advisers now owns 31,652 shares of the construction company's stock worth $179,000 after purchasing an additional 2,452 shares during the period. Oppenheimer & Co. Inc. boosted its position in shares of Cemex by 21.0% during the first quarter. Oppenheimer & Co. Inc. now owns 14,431 shares of the construction company's stock worth $81,000 after acquiring an additional 2,505 shares during the last quarter. Legacy Wealth Asset Management LLC boosted its position in shares of Cemex by 3.4% during the first quarter. Legacy Wealth Asset Management LLC now owns 77,957 shares of the construction company's stock worth $437,000 after acquiring an additional 2,570 shares during the last quarter. Finally, Envestnet Portfolio Solutions Inc. boosted its position in shares of Cemex by 26.4% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 13,011 shares of the construction company's stock worth $73,000 after acquiring an additional 2,720 shares during the last quarter. 82.97% of the stock is currently owned by institutional investors.

Cemex Stock Down 1.7%

CX stock traded down $0.15 during mid-day trading on Monday, hitting $8.27. The stock had a trading volume of 8,687,745 shares, compared to its average volume of 12,858,189. The stock has a market capitalization of $11.98 billion, a price-to-earnings ratio of 8.11, a PEG ratio of 1.04 and a beta of 1.38. The company has a fifty day moving average of $7.13 and a 200 day moving average of $6.38. Cemex S.A.B. de C.V. has a 1-year low of $4.89 and a 1-year high of $8.46. The company has a current ratio of 0.86, a quick ratio of 0.61 and a debt-to-equity ratio of 0.37.

Cemex (NYSE:CX - Get Free Report) last posted its earnings results on Thursday, July 24th. The construction company reported $0.23 EPS for the quarter, topping the consensus estimate of $0.18 by $0.05. Cemex had a return on equity of 6.89% and a net margin of 9.61%. The business had revenue of $4.13 billion during the quarter, compared to the consensus estimate of $4.20 billion. On average, equities analysts expect that Cemex S.A.B. de C.V. will post 0.69 EPS for the current fiscal year.

Cemex Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, June 26th. Stockholders of record on Tuesday, June 17th were paid a dividend of $0.0224 per share. The ex-dividend date was Tuesday, June 17th. This represents a $0.09 dividend on an annualized basis and a dividend yield of 1.08%. Cemex's dividend payout ratio (DPR) is currently 7.84%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on CX shares. Bradesco Corretora set a $7.50 price target on shares of Cemex and gave the company a "neutral" rating in a research note on Tuesday, April 15th. Royal Bank Of Canada increased their target price on shares of Cemex from $5.00 to $5.25 and gave the company an "underperform" rating in a research note on Tuesday, April 29th. Barclays reissued an "overweight" rating and issued a $9.00 target price (up previously from $8.00) on shares of Cemex in a research note on Tuesday, July 15th. Itau BBA Securities downgraded shares of Cemex from an "outperform" rating to a "market perform" rating in a research note on Tuesday, June 3rd. Finally, Wall Street Zen downgraded shares of Cemex from a "buy" rating to a "hold" rating in a research note on Sunday, July 20th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and three have given a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $7.74.

Get Our Latest Stock Analysis on Cemex

Cemex Profile

(Free Report)

CEMEX, SAB. de C.V., together with its subsidiaries, produces, markets, distributes, and sells cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and services worldwide. The company offers gray ordinary portland, white portland, oil-well, and blended cement products; mortar; and standard ready-mix, architectural and decorative, rapid-setting, fiber-reinforced, fluid-fill, roller-compacted, self-consolidating, pervious, and antibacterial, and other concrete products.

Featured Articles

Institutional Ownership by Quarter for Cemex (NYSE:CX)

Should You Invest $1,000 in Cemex Right Now?

Before you consider Cemex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cemex wasn't on the list.

While Cemex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines